INZ-701

DB17629InvestigationalProtein Based Therapies

INZ-701 is an enzyme replacement therapy under development with the intention to be used for the treatment of calcification disorders of the circulatory system, bones, and kidneys.

Mechanism: Pharmacologically active on Ectonucleotide pyrophosphatase/phosphodiesterase family member 1
Curator reviewed
Also known as: Recombinant human ectonucleotide pyrophosphatase/phosphodiesterase 1 fused to the Fc fragment of IGG1 (INZ-701)
Code names: INZ-701

Resolves to

Compound

UNII8ZH1P9LXW1

Targets

P22413ENPP1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with INZ-701, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account